mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.03 |